x

Cerca un progetto di ricerca

* (*) campo obbligatorio

184 Risultato/i

Ordinato per

Progetti di ricerca terminati = Finanziato da un ente associato a IRDiRC = Membro di una ERN =

Progetti di ricerca

AUSTRIA

WIEN
WIEN

Deep Learning for Precision Diagnostics of Brain Tumors
Allgemeines Krankenhaus der Stadt Wien
Abteilung für Neuropathologie und Neurochemie

AUSTRIA

WIEN
WIEN

Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

CANADA

Ontario
TORONTO

GERMANIA

Baden-Württemberg
HEIDELBERG

Finanziato da un ente associato a IRDiRCERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

Finanziato da un ente associato a IRDiRCGliMR2.0: Glioma MR Imaging 2.0 - AT
Institution: Information not provided - AT

AUSTRIA

WIEN
WIEN

Improved Visualization and Resection of Brain Tumors with Quantitative Fluorescence and Optical Coherence Tomography
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Finanziato da un ente associato a IRDiRCITCC-P4: Pediatric Preclinical Proof of Concept Platform - AT
Medizinische Universität Wien
Institut für Krebsforschung

GERMANIA

Nordrhein-Westfalen
MÜNSTER

Functional role of genes and pathways in histone H3 mutated gliomas
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

GERMANIA

Rheinland-Pfalz
MAINZ

GLIOPT -Glioma patients in ambulatory care - Optimization of psychosocial care in neurooncological patients
Universitätsmedizin Mainz
Universitäres Centrum für Tumorerkrankungen (UCT) Mainz

IRLANDA

County Dublin
DUBLIN

PORTOGALLO

SUL
LISBOA

Role of protein kinase WNK2 as a tumour suppressor gene in malignant gliomas
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Unidade de Investigação e Desenvolvimento

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCMechanistic models using Machine Learning for therapeutic targets discovery and drug repurposing in Rare Diseases
ISCIII - Instituto de Salud Carlos III
Centro de Investigación Biomédica en Red de Enfermedades Raras

STATI UNITI

South Dakota
SIOUX FALLS

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCEstablishing the genomic landscape of human atypical meningiomas
Institution: Information not provided - US

SVEZIA

Region Uppsala
UPPSALA

Molecular mechanisms of the origine of glioma development
Uppsala Universitet
Department of immunology, Genetics and Pathology, IGP

SVIZZERA

Suisse Alémanique
BERN

Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla
Universitätsspital Inselspital
Universitätsinstitut für Diagnostische und Interventionelle Neuroradiologie

SVIZZERA

Suisse Alémanique
ZÜRICH

To reveal and target molecular interactions causative for pro-invasive signaling in malignant brain tumors
Universitäts-Kinderspital Zürich
Abteilung Onkologie - Experimental Infectious Diseases and Cancer Research

AUSTRIA

WIEN
WIEN

Finanziato da un ente associato a IRDiRCBRCAddict: Harnessing BRCAness as a therapeutic target in high-risk pediatric solid tumors - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Kinder- und Jugendheilkunde

CANADA

Ontario
TORONTO

Finanziato da un ente associato a IRDiRCMolecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Hospital for Sick Children, Research Institute

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCIdentification and characterization of genes involved in the genesis and progression of pediatric astrocytomas
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCRole of chromatin remodeling in the genesis of pediatric and young adult astrocytomes
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCThe ICHANGE (International CHildhood Astrocytomas iNtegrated Genomics and Epigenomics) Consortium
Montreal Children's Hospital Research Institute - McGill University
Department of Pediatrics / Département de pédiatrie

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCTackling childhood brain cancer at the root to improve survival and quality of life
The Research Institute of the McGill University Health Centre

GERMANIA

Baden-Württemberg
HEIDELBERG

INFORM-Registry: INdividualized Therapy FOr Relapsed Malignancies in Childhood
Deutsches Krebsforschungszentrum
Klinische Kooperationseinheit Pädiatrische Onkologie

GERMANIA

Hamburg
HAMBURG

International HIT-MED Registry (I-HIT-MED) for Children, Adolescents, and Adults With Medulloblastoma, Ependymoma, Pineoblastoma, CNS-primitive Neuroectodermal Tumour
UKE - Universitätsklinikum Hamburg-Eppendorf
Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie

GERMANIA

Nordrhein-Westfalen
MÜNSTER

Clinical and molecular features predicting outcome in children with atypical teratoid/rhabdoid tumour (AT/RT)
Institut für Neuropathologie der Medizinischen Fakultät Münster
Institut für Neuropathologie

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas
King's College Hospital
King's College Hospital NHS Foundation Trust HQ

SPAGNA

Cataluña
ESPLUGUES DE LLOBREGAT

Finanziato da un ente associato a IRDiRCDevelopment of epigenetic classifiers for pediatric cancer (ECPC)
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu

STATI UNITI

South Dakota
SIOUX FALLS

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCPrecision medicine for pediatric low-grade gliomas
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCFunctional genomic analysis of neural crest development
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCMir-155 and runx function in neurofibroma tumorigenesis and therapy
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRegulation of medulloblastoma metastasis by emp1
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRegulation of shh signaling by cellular energetics
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTargeting mechanisms of medulloblastoma formation
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTargeting wee1 in myc driven medulloblasoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCHigh-throughput Screening for SHH medulloblastoma
Institution: Information not provided - US

SVEZIA

Region Stockholm
SOLNA

SVEZIA

Region Stockholm
SOLNA

INTENT: innovative approach for treatment of neuroblastoma and medulloblastoma
Karolinska Institutet
Department of microbiology, tumor and cell biology (MTC)

AUSTRIA

SALZBURG
SALZBURG

Adjuvant multimodal metabolic therapy of neuroblastoma
Universitätsklinikum der Paracelsus Medizinischen Privatuniversität
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

WIEN
WIEN

Identifying immunological characteristics associated with disease progression in low grade glioma
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Quantitative measurement of 5-ALA fluorescence for improved detection of low-grade gliomas
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

MR-Fingerprinting for the Prediction of the Response of Vestibular Schwannomas to Gamma Knife Radiosurgery
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Neurochirurgie

AUSTRIA

WIEN
WIEN

Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors - a pilot study
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für klinische Pharmakologie

AUSTRIA

WIEN
WIEN

Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute

COREA DEL SUD

KOREA, REPUBLIC OF
SEOUL

FINLANDIA

Finland
HELSINKI

Finanziato da un ente associato a IRDiRCLessons learned from the embryo to help understand neuroblastoma formation
University of Helsinki
Department of Biochemistry and Developmental Biology

FRANCIA

AUVERGNE-RHONE-ALPES
LYON

GERMANIA

Nordrhein-Westfalen
KÖLN

Molecular basis for tumor suppression and spontanous regression in neuroblastoma
Universitätsklinikum Köln
Pädiatrische Onkologie und Hämatologie

GERMANIA

Sachsen
LEIPZIG

NB-MolBiol-2020: Study on the clinical significance of cell biological parameters in diagnostics, prognosis and therapy for neuroblastoma patients
Zentrum für Frauen- und Kindermedizin am Universitätsklinikum Leipzig
Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCNew nanotools for the treatment of metastatic neuroblastoma
Vall d'Hebron Institut de Recerca VHIR
Vall d'Hebron Institut de Recerca

SPAGNA

Cataluña
BARCELONA

Finanziato da un ente associato a IRDiRCQuatsomes as a novel nanomaterial platform for nucleic acids delivery
Vall d'Hebron Institut de Recerca VHIR
Vall d'Hebron Institut de Recerca

SPAGNA

Comunidad Valenciana
VALENCIA

Finanziato da un ente associato a IRDiRCNeuroblastoma: mechanotherapeutic strategies based on 3D model and patient derived tumor with vitronectin rich microenvironment
INCLIVA - Sede central
Fundación Investigación Clínico de Valencia - Instituto de Investigación Sanitaria

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCCombination of nanomedicine and immunotherapy for the treatment of neuroblastoma
Hospital Infantil Universitario Niño Jesús
Servicio de Oncohematología

STATI UNITI

Maryland
BETHESDA

Finanziato da un ente associato a IRDiRCDrug repurposing screening for rare and neglected diseases
National Center for Advancing Translational Sciences (NCATS-NIH)
Therapeutic Development Branch

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTargeting olig2 co-regulators for malignant glioma therapy
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCDeconstruct tumor microenvironment in medulloblastoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTargeting bet-bromodomains in neuroblastoma
Institution: Information not provided - US

SVIZZERA

Suisse Romande
LAUSANNE

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

AUSTRIA

WIEN
WIEN

CDK 4/6 inhibitors as a new therapeutic strategy in pediatric brain tumors
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

AUSTRIA

WIEN
WIEN

Decoding cellular senescence in glioblastoma (GlioAge)
Allgemeines Krankenhaus der Stadt Wien
Abteilung für Neuropathologie und Neurochemie

FINLANDIA

Finland
KUOPIO

New therapeutic treatments for malignant glioma
Itä-Suomen yliopisto
A.I.Virtanen -Instituutti

FINLANDIA

Finland
KUOPIO

Finanziato da un ente associato a IRDiRCLAT1-targeted prodrugs for improved drug delivery to invasive glioma cells
University of Eastern Finland
Faculty of Health Sciences

FRANCIA

AUVERGNE-RHONE-ALPES
ILLKIRCH

Systems biology of integrin inhibition-induced apoptosis for novel glioblastoma treatment
LBP - Laboratory of Bioimaging and Pathologies
Tumoral signaling and therapeutic targets

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Development of a new drug therapy for glioblastoma
Parc scientifique et technologiques de Luminy
Pharmaxon

GERMANIA

Nordrhein-Westfalen
DÜSSELDORF

Targeting HOTAIRM1 in Glioblastoma Multiforme
Universitätsklinikum Düsseldorf
Hirntumor-Referenzzentrum der DGNN

PORTOGALLO

CENTRO
BRAGA

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

SPAGNA

Andalucía
SEVILLA

Finanziato da un ente associato a IRDiRCClinical and preclinical study of the "immune-barrier" effect in the glioblastoma environment: A novel tool to improve cancer patients´ stratification for immunotherapy
Hospital Universitario Virgen del Rocío
FISEVI - Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

SPAGNA

Baleares
PALMA DE MALLORCA

Finanziato da un ente associato a IRDiRCIntegrative characterization of molecular biomarkers for the precision diagnosis and treatment of patients with glioblastoma
IdISBa - Fundació Institut d'Investigació Sanitaria Illes Balears
BIOCANCER: Grupo de Biología Celular del Cáncer

SPAGNA

Castilla - La Mancha
ALBACETE

Finanziato da un ente associato a IRDiRCNanomedicine for glioblastoma therapy
Universidad de Castilla-La Mancha. Campus de Albacete. Facultad de Medicina
Unidad Neurodeath

SPAGNA

Cataluña
L'HOSPITALET DE LLOBREGAT

Finanziato da un ente associato a IRDiRCMR Spectroscopy prognostic assessment of brain gliomas (MRS-PROG)
IDIBELL - Instituto de Investigación Biomédica de Bellvitge
Instituto de Investigación Biomédica de Bellvitge

SPAGNA

Galicia
SANTIAGO DE COMPOSTELA

Finanziato da un ente associato a IRDiRCSilk-fibroin interventional nano-trap for the treatment of glioblastoma
Universidad de Santiago de Compostela. Facultad de Farmacia
I+D Farma

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCNanomedicine for glioblastoma therapy
Hospital Universitario Ramón y Cajal
Servicio de Oncología Médica

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCValidation of the MGMT epigenetic biomarker in liquid biopsy as a non-invasive test in patients with gliomas
IdiPAZ - Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Fundación para la Investigación Biomédica del H.U. La Paz

SPAGNA

Navarra
PAMPLONA

Finanziato da un ente associato a IRDiRCRole of RNU6 isolated from circulating exosomes as a potential diagnostic and follow-up biomarker for patients with glioblastoma
CIMA - Centro de Investigación Médica Aplicada
Grupo de Terapias avanzadas para tumores sólidos pediátricos

SPAGNA

Navarra
PAMPLONA

Finanziato da un ente associato a IRDiRCPlasma extracellular vesicles (EVs): the key for precision medicine in Glioblastoma
IdiSNA - Instituto de Investigación Sanitaria de Navarra
Instituto de Investigación Sanitaria de Navarra

SPAGNA

País Vasco
DERIO

Finanziato da un ente associato a IRDiRCPlasma extracellular vesicles (EVs): the key for precision medicine in Glioblastoma
Centro de Investigación Cooperativa en Biociencias (CIC bioGUNE)
Centro de Investigación Cooperativa en Biociencias

STATI UNITI

Maryland
BETHESDA

Finanziato da un ente associato a IRDiRCCharacterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma
National Center for Advancing Translational Sciences (NCATS-NIH)
Chemistry Technologies

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCImmunobiology of malignant glioma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCComparative mammalian genomics
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCGlioblastoma stem cell-derived pericytes and cancer invasion
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCModeling malignant progression in glioma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCNeuronal activity-regulated mechanisms of glioma growth
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCNeuroimmunology of malignant brain tumors: innate mechanisms
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRole of glud2 as a metabolic driver of gliomas with idh1 mutations
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCSystemic gene therapy for glioblastoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCThe mayo gbm xenograft national resource
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTargeting epha2 in glioblastoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCSelective targeting of glioma stem cells through sema3c/plexind1
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCUbiquitination and deubiquitination of c-myc in glioblastoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCChromatin modifications in gbm-propagating cells
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCCellular plasticity and equilibrium in gbm progression
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCExploiting mtap deletion for gbm therapeutics
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCMechanisms of riok2 function in glioblastoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCThe role of tumor associated macrophages in glioblastoma
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTargeting kif11 to treat glioblastoma invasion and proliferation
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCPhysical-chemical aspects of cell and tissue excitability
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCTherapeutically relevant targets of twist1 dimers in glioma
Institution: Information not provided - US

SVIZZERA

Suisse Alémanique
BASEL

SVIZZERA

Suisse Alémanique
BERN

SVIZZERA

Suisse Alémanique
ZÜRICH

Harnessing novel technologies for precision medicine in pediatric diffuse midline glioma
Universitäts - Kinderspital Zürich - Eleonorenstiftung
Onkologie

SVIZZERA

Suisse Romande
LAUSANNE

Epigenetic landscape of gliomas and their implications for tumor biology and treatment of cancer II
Centre Hospitalier Universitaire Vaudois CHUV
Laboratoire de biologie et génétique des tumeurs cérébrales (LBGT)

Progetti di ricerca multicentrici